CD8A and COVID-19: In fact, in our FluMist and rVSV-based immunization models for influenza and COVID-19, respectively, we had the opportunity to enumerate immunodominant CD8+ Tconv cells, which were markedly increased in animals receiving 5-OP-RU-adjuvanted vaccines.